Bioject Medical Technologies In (BJCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Sales | 1,157 | 1,188 | 1,497 | 1,535 | 1,676 |
| Cost of Goods | 808 | 809 | 945 | 1,001 | 978 |
| Gross Profit | 349 | 379 | 551 | 534 | 697 |
| Operating Expenses | 1,751 | 1,695 | 1,887 | 745 | 1,783 |
| Operating Income | -593 | -507 | -390 | -210 | -108 |
| Interest Expense | 3 | 30 | 48 | 47 | 52 |
| Other Income | 40 | -5 | 59 | 83 | -142 |
| Pre-tax Income | -556 | -543 | -380 | -174 | -301 |
| Net Income Continuous | -556 | -543 | -380 | -174 | -301 |
| Net Income | $-556 | $-543 | $-380 | $-174 | $-301 |
| EPS Basic Total Ops | -0.03 | -0.03 | -0.03 | -0.01 | -0.02 |
| EPS Basic Continuous Ops | -0.03 | -0.03 | -0.02 | -0.01 | -0.02 |
| EPS Diluted Total Ops | -0.03 | -0.03 | -0.03 | -0.01 | -0.02 |
| EPS Diluted Continuous Ops | -0.03 | -0.03 | -0.02 | -0.01 | -0.02 |
| EBITDA(a) | $-456 | $-358 | $-236 | $-47 | $79 |